Improvements in post-stroke pain, brain fog, dexterity, vision, and spasticity after PSE treatment by Dr. Tobinick, 2 years after stroke. Filmed on September 16, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Immediate improvement in balance, walking, vision, spasticity, and brain fog after PSE treatment performed by Danielle Ucci, PA-C, 9 months after stroke. Filmed on September 5, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Improved quality of life, spasticity, fatigue, and hand function after perispinal etanercept treatment by Edward Tobinick, M.D., 4 years after stroke. Filmed on August 12, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Immediate improvement in left-sided neglect, speech, sensation, and left arm flexion after PSE treatment by Dr. Tobinick, 4 years after hemorrhagic stroke. Filmed on July 24, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Improvements in walking, vision, spasticity, speech, sensation, and taste after PSE treatment by Dr. Tobinick, 6.5 years after stroke. Filmed on July 10 & July 15, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Rapid improvement in fine motor function, pain, spasticity, and speech after PSE treatment by Dr. Tobinick, over 2 years after hypoxic brain injury resulting in Lance-Adams Syndrome. Filmed on June 24, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Improvement in peripheral vision, post-stroke pain, spasticity, sensation, and swallowing after PSE treatment performed by Danielle Ucci, PA-C, 4 months after stroke. Filmed on June 25, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Request a consultation today | Terms of Use & Disclaimer
Immediate improvement in walking, sensation, and taste after PSE treatment by Dr. Tobinick, years after multiple strokes. Filmed on June 10, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Improvement in central post-stroke pain, sensation, spasticity, vision, walking, and taste after PSE treatment by Dr. Tobinick, 2 years after hemorrhagic stroke. Filmed on April 8, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use
Rapid improvement in cervical dystonia (spasmodic torticollis) and dysarthria after PSE treatment by Dr. Tobinick, 4.5 years after traumatic brain injury and hemorrhagic stroke. Filmed on May 20, 2025 at the Institute of Neurological Recovery (INR®) in Boca Raton, Florida.
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use